Comparison between Healthcare Global IPO and Infibeam Incorporation IPO.
Healthcare Global IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Infibeam Incorporation IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Healthcare Global IPO is up to ₹649.64 Cr whereas the issue size of the Infibeam Incorporation IPO is up to ₹450.00 Cr. The final issue price of Healthcare Global IPO is ₹218.00 per share and of Infibeam Incorporation IPO is ₹432.00 per share.
| Healthcare Global IPO | Infibeam Incorporation IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹205.00 per share | ₹360.00 per share |
| Issue Price (Upper) | ₹218.00 per share | ₹432.00 per share |
| Issue Price (Final) | ₹218.00 per share | ₹432.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 65 shares | 34 shares |
| Fresh Issue Size | 1,16,00,000 shares | 1,04,16,666 shares |
| Fresh Issue Size (Amount) | up to ₹252.88 Cr | up to ₹450.00 Cr |
| OFS Issue Size | 1,82,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹396.76 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,98,00,000 shares | 1,04,16,666 shares |
| Issue Size Total (Amount) | up to ₹649.64 Cr | up to ₹450.00 Cr |
Healthcare Global IPO opens on Mar 16, 2016, while Infibeam Incorporation IPO opens on Mar 21, 2016. The closing date of Healthcare Global IPO and Infibeam Incorporation IPO is Mar 18, 2016, and Mar 23, 2016, respectively.
| Healthcare Global IPO | Infibeam Incorporation IPO | |
|---|---|---|
| Anchor Bid Date | Mar 15, 2016 | |
| Issue Open | Mar 16, 2016 | Mar 21, 2016 |
| Issue Close | Mar 18, 2016 | Mar 23, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Mar 30, 2016 | Apr 04, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Healthcare Global IPO P/E ratio is , as compared to Infibeam Incorporation IPO P/E ratio of .
| Healthcare Global IPO | Infibeam Incorporation IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹1854.66 Cr. | ₹2293.55 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Healthcare Global IPO Retail Individual Investors (RII) are offered 29,80,000 shares while in Infibeam Incorporation IPO retail investors are offered 29,80,000 shares. Qualified Institutional Buyers (QIB) are offered 89,40,000 shares in Healthcare Global IPO and 78,12,501 shares in Infibeam Incorporation IPO.
| Healthcare Global IPO | Infibeam Incorporation IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,34,10,000 shares | |
| Market Maker Reservation | ||
| QIB | 89,40,000 shares | 78,12,501 shares |
| NII | 44,70,000 shares | 15,62,499 shares |
| RII | 29,80,000 shares | 10,41,666 shares |
| Employee | ||
| Others | ||
| Total | 2,98,00,000 shares | 1,04,16,666 shares |
Healthcare Global IPO subscribed 1.56x in total, whereas Infibeam Incorporation IPO subscribed 1.11x.
| Healthcare Global IPO | Infibeam Incorporation IPO | |
|---|---|---|
| QIB (times) | 2.36x | 0.86x |
| NII (times) | 0.43x | 2.23x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.83x | 1.31x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.56x | 1.11x |
